Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Gross Margin: 2011-2012

Historic Gross Margin for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to 68.38%.

  • Sonoma Pharmaceuticals' Gross Margin rose 342.00% to 69.80% in Q4 2012 from the same period last year, while for Dec 2012 it was 69.11%, marking a year-over-year decrease of 119.00%. This contributed to the annual value of 68.38% for FY2012, which is 542.00% up from last year.
  • As of FY2012, Sonoma Pharmaceuticals' Gross Margin stood at 68.38%, which was up 8.61% from 62.96% recorded in FY2011.
  • In the past 5 years, Sonoma Pharmaceuticals' Gross Margin registered a high of 68.38% during FY2012, and its lowest value of 62.96% during FY2011.
  • Its 2-year average for Gross Margin is 65.67%, with a median of 65.67% in 2011.
  • Data for Sonoma Pharmaceuticals' Gross Margin shows a peak YoY surged of 542bps (in 2012) over the last 5 years.
  • Over the past 2 years, Sonoma Pharmaceuticals' Gross Margin (Yearly) stood at 62.96% in 2011, then soared by 542bps to 68.38% in 2012.